2014
DOI: 10.1128/jcm.01918-14
|View full text |Cite
|
Sign up to set email alerts
|

Drug-Resistant Tubercular Uveitis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

1
2
0

Year Published

2017
2017
2023
2023

Publication Types

Select...
5
2

Relationship

1
6

Authors

Journals

citations
Cited by 18 publications
(3 citation statements)
references
References 6 publications
1
2
0
Order By: Relevance
“…The mutations were detected at codon 531 (n = 4), 526 (n = 1), and 516 (n = 1) in the rpoB gene; and codon 315 (n = 2) of the katG gene. The findings are similar to results obtained in previous studies 16,20,21,25 as these are the most commonly encountered mutations contributing to drug resistance for rifampicin and isoniazid, respectively.…”
Section: Discussionsupporting
confidence: 91%
See 1 more Smart Citation
“…The mutations were detected at codon 531 (n = 4), 526 (n = 1), and 516 (n = 1) in the rpoB gene; and codon 315 (n = 2) of the katG gene. The findings are similar to results obtained in previous studies 16,20,21,25 as these are the most commonly encountered mutations contributing to drug resistance for rifampicin and isoniazid, respectively.…”
Section: Discussionsupporting
confidence: 91%
“…MTBDRplus line probe assay is a commercially available diagnostic technique that is currently recommended for smear positive pulmonary specimen and from culture. 14 To the best of our knowledge, there are only two studies 15,16 addressing the role of MTBDRplus assay, on 11 and five cases, respectively, for the diagnosis of IOTB and detection of resistance simultaneously. We, therefore, evaluated the diagnostic potential of MTBDRplus assay on substantial number of vitreous fluid samples to add to the existing literature in this field.…”
Section: Introductionmentioning
confidence: 99%
“…[ 22 ] I also described ocular signs predictive of tubercular uveitis (Scopus citations, 158). [ 23 ] In 2014, we reported multidrug resistant tubercular uveitis for the first time globally,[ 24 ] and in 2015, its successful treatment. [ 25 ] We were among the first in the world to successfully treat TB choroidal granuloma with anti-vascular endothelial growth factor (anti-VEGF), exploiting the vascularization of hypoxic TB granulomas.…”
Section: Beginning Of a Cascade In Ocular Tb Researchmentioning
confidence: 99%